RAYMED LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2023 ,inter alia, to consider and approve Unaudited Standalone Financial Results as per Regulation 33 of SEBI (LODR) Regulations, 2015 for quarter and half year ended September 30, 2023 together with the Limited Review Report.